APA (7th ed.) Citation

JA, B., X, Z., S, B., MA, F., C, B. F., H, F. H., . . . EA, S. (2022). Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability. Nature nanotechnology, 17(3), 319. https://doi.org/10.1038/s41565-021-01048-2

Chicago Style (17th ed.) Citation

JA, Burke, et al. "Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability." Nature Nanotechnology 17, no. 3 (2022): 319. https://doi.org/10.1038/s41565-021-01048-2.

MLA (9th ed.) Citation

JA, Burke, et al. "Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability." Nature Nanotechnology, vol. 17, no. 3, 2022, p. 319, https://doi.org/10.1038/s41565-021-01048-2.